Cyclin B1 expression in response to abrogation of the radiation-induced G2/M block in HeLa cells

T Theron1, L Böhm

  • 1Department of Radiation Oncology, University of Stellenbosch Medical Faculty, Tygerberg, South Africa.

Cell Proliferation
|September 24, 1998
PubMed

Insights

DNA damage triggers a G2 cell cycle block, crucial for DNA repair. Pentoxifylline abrogates this block by restoring cyclin B1 expression, highlighting its role in cell cycle regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • The G2 block is a critical cellular response to DNA damage, independent of p53.
  • This delay is believed to facilitate DNA repair, making its molecular mechanisms a key research area.

Purpose of the Study:

  • To investigate the role of cyclin B1 expression in the G2 cell cycle block.
  • To determine the mechanism by which pentoxifylline abrogates the G2 block.

Main Methods:

  • Utilized pentoxifylline, a G2 delay abrogator.
  • Measured cyclin B1 expression levels in relation to G2 phase cells.
  • Assessed the effect of irradiation and pentoxifylline treatment on cyclin B1/G2 ratios.

Main Results:

  • Irradiation was found to decrease cyclin B1 expression.
  • Pentoxifylline treatment restored cyclin B1 expression to control levels.
  • These findings indicate that cyclin B1 suppression is integral to G2 block formation.

Conclusions:

  • Suppression of cyclin B1 is a key factor in the G2 cell cycle delay.
  • Pentoxifylline's mechanism involves restoring cyclin B1 expression in G2-blocked cells.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...